Massachusetts legislation · 194th General Court
Massachusetts H4489: to ensure affordable prescription medications through accountability standards
Status: In committee, June 17, 2026
What the bill says
From the introduced text, September 18, 2025:
SECTION 1. Section 1 of chapter 6D of the General Laws, as appearing in the 2022 Official Edition, is hereby amended by inserting after the definition of “Alternative payment methodologies or methods” the following definition:- “Biosimilar”, a drug that is produced or distributed pursuant to a biologics license application approved under 42 U.S.C. 262(k)(3). SECTION 2. Said chapter 6D, as so appearing, is hereby further amended by adding the following section:- Section 23. (a) For the purposes of this section, “Manufacturer” shall mean an entity that manufactures a pharmaceutical drug. (b) The commission may require a manufacturer specified in subsection (c) to disclose to the commission within a reasonable time information relating to the manufacturer’s pricing of that drug, on a standard reporting form developed by the commission with the input of the manufacturers, which includes, but shall not be limited to, the following: (1) A schedule of the drug’s wholesale acquisition cost increases over the previous 5 calendar years; (2) The manufacturer’s aggregate, company-level research and development and other relevant capital expenditures, including facility construction, for the most recent year for which final audited data are available; (3) A written, narrative description, suitable for public release, of factors that contributed to reported changes in wholesale acquisition cost during the previous 5 calendar years; and (4) Any other information that …
Sponsors
- Services, Joint Committee on Financial (I) · primary sponsor
- Christine Barber (D)
- James Arena-DeRosa (D)
- Mike Connolly (D, 26th Middlesex)
- James Hawkins (D, 2nd Bristol)
- Natalie Higgins (D, 4th Worcester)
- Patrick Kearney (D, 4th Plymouth)
- Mary Keefe (D, 15th Worcester)
- Jason Lewis (D, Fifth Middlesex)
- Hadley Luddy (D)
- James O'Day (D, 14th Worcester)
- Tommy Vitolo (D, 15th Norfolk)
Latest actions
- : Reporting date extended to Friday, July 31, 2026
- : Reporting date extended to Monday, June 15, 2026
- : Reporting date extended to Wednesday, March 18, 2026
- : Reported favorably by committee and referred to the committee on Health Care Financing
- : New draft of H1092
- : Reported from the committee on Financial Services
Votes
- Committee Vote - Joint Committee on Financial Services (September 8, 2025): 11 yea, 0 nay, passed
Common questions
- What is H4489?
- H4489 is a bill in the Massachusetts Legislature (194th General Court): to ensure affordable prescription medications through accountability standards.
- What is the status of H4489?
- In committee as of June 17, 2026. Latest action: Reporting date extended to Friday, July 31, 2026 (June 17, 2026).
- Who sponsored H4489?
- Services, Joint Committee on Financial (I), with 11 co-sponsors.
- Where is the official record for H4489?
- On the Massachusetts Legislature website: https://malegislature.gov/Bills/194/H4489
Source: official Massachusetts record. Tracked by Delilah, AI for legislation across all 50 states and Congress.